Lupin Pharmaceuticals, indian pharma company, have ended all ongoing litigation by the means of settlement over Lunesta (Eszopicolone) tablets, with Dainippon Sumitomo Pharma Co's subsidiary Sunovion Pharmaceuticals Inc.
AS per the settlement, Lupin can sell Lunesta's generic version from November 2013 or it may be extended by six months if pediatric extension will be granted to Lunesta
No comments:
Post a Comment